Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
  Users Online: 192 Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  

    Article Cited by others


Effect of dipeptidyl peptidase 4 inhibitors on acute and subacute models of inflammation in male Wistar rats: An experimental study

Kagal Urmila Anil, Angadi Netravathi Basavaraj, Matule Somnath Mallikarjun

Year : 2017| Volume: 7| Issue : 1 | Page no: 26-31

   This article has been cited by
1 Vildagliptin attenuates acetic acid-induced colitis in rats via targeting PI3K/Akt/NF?B, Nrf2 and CREB signaling pathways and the expression of lncRNA IFNG-AS1 and miR-146a
Marina R. Fouad,Rania M. Salama,Hala F. Zaki,Ayman E. El-Sahar
International Immunopharmacology. 2021; 92: 107354
[Pubmed]  [Google Scholar] [DOI]
2 The role of incretins and incretin-based drugs in autoimmune diseases
Shabnam Radbakhsh,Stephen L. Atkin,Luis E. Simental-Mendia,Amirhossein Sahebkar
International Immunopharmacology. 2021; 98: 107845
[Pubmed]  [Google Scholar] [DOI]
3 Combination of vitamin D and dipeptidyl peptidase-4 inhibitors (VIDPP-4i) as an immunomodulation therapy for autoimmune diabetes
Marcelo Maia Pinheiro,Felipe Moura Maia Pinheiro,Susana Nogueira Diniz,Andrea Fabbri,Marco Infante
International Immunopharmacology. 2021; 95: 107518
[Pubmed]  [Google Scholar] [DOI]
4 Non-insulin anti-diabetic agents in patients with type 2 diabetes and COVID-19: A Critical Appraisal of Literature
Awadhesh Kumar Singh,Ritu Singh,Banshi Saboo,Anoop Misra
Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2021; 15(1): 159
[Pubmed]  [Google Scholar] [DOI]
5 L’inflammation chronique perturbe la mobilisation et la migration des cellules souches, altérant le fonctionnement de notre système naturel de réparation et de renouvellement : nouvelle approche thérapeutique complémentaire et combinée dans la prise en charge de maladies chroniques inflammatoires ?
Véronique Traynard
Hegel. 2021; N° 1(1): 37
[Pubmed]  [Google Scholar] [DOI]
6 Design, Synthesis and Biological Evaluation of 2-Aminobenzimidazole Derivatives as DPP4 Inhibitors
Sreeja Sunil,Arul G.D.A. Smith,Mathan S.
Current Bioactive Compounds. 2020; 16(5): 696
[Pubmed]  [Google Scholar] [DOI]
7 COVID-19 and comorbidities: A role for dipeptidyl peptidase 4 ( DPP4 ) in disease severity?
Margaret F. Bassendine,Simon H. Bridge,Geoffrey W. McCaughan,Mark D. Gorrell
Journal of Diabetes. 2020;
[Pubmed]  [Google Scholar] [DOI]
8 Dipeptidyl-peptidase-4 inhibitors in type 2 diabetes and COVID-19: From a potential repurposed agent to a useful treatment option
AwadheshKumar Singh,Ritu Singh
Journal of Diabetology. 2020; 11(3): 131
[Pubmed]  [Google Scholar] [DOI]
9 Combined dipeptidyl peptidase-4 inhibitor with low-dose testosterone exerts greater efficacy than monotherapy on improving brain function in orchiectomized obese rats
Puntarik Keawtep,Wasana Pratchayasakul,Apiwan Arinno,Nattayaporn Apaijai,Titikorn Chunchai,Sasiwan Kerdphoo,Thidarat Jaiwongkum,Nipon Chattipakorn,Siriporn C. Chattipakorn
Experimental Gerontology. 2019; 123: 45
[Pubmed]  [Google Scholar] [DOI]
10 Anti-inflammatory and antinociceptive activities of glucagon-like peptides: evaluation of their actions on serotonergic, nitrergic, and opioidergic systems
Duygun Altintas Aykan,Murat Kesim,Beyza Ayan,Aysegül Kurt
Psychopharmacology. 2019;
[Pubmed]  [Google Scholar] [DOI]
11 Saxagliptin mitigates airway inflammation in a mouse model of acute asthma via modulation of NF-kB and TLR4
Manar G. Helal,Nermeen A. Megahed,Ahmed G. Abd Elhameed
Life Sciences. 2019; 239: 117017
[Pubmed]  [Google Scholar] [DOI]
12 Type 2 diabetes – An autoinflammatory disease driven by metabolic stress
Laura Lopez,Karin Garrie,Mark D. Turner
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 2018;
[Pubmed]  [Google Scholar] [DOI]
13 Nephroprotective effect of saxagliptin against gentamicin-induced nephrotoxicity, emphasis on anti-oxidant, anti-inflammatory and anti-apoptic effects
Manar Gamal Helal,Marwa Mohamed Abdel Fattah Zaki,Eman Said
Life Sciences. 2018; 208: 64
[Pubmed]  [Google Scholar] [DOI]
14 Ameliorative potential of sitagliptin and/or resveratrol on experimentally-induced clear cell renal cell carcinoma
Ahmed M. Kabel,Aliaa Atef,Remon S. Estfanous
Biomedicine & Pharmacotherapy. 2018; 97: 667
[Pubmed]  [Google Scholar] [DOI]
15 Dipeptidyl peptidase-4 inhibitors (DPP-4i) combined with vitamin D3: An exploration to treat new-onset type 1 diabetes mellitus and latent autoimmune diabetes in adults in the future
Marcelo Maia Pinheiro,Felipe Moura Maia Pinheiro,Maria Luisa Trabachin
International Immunopharmacology. 2018; 57: 11
[Pubmed]  [Google Scholar] [DOI]
16 Effect of dipeptidyl peptidase-4 inhibitors on circulating tumor necrosis factor-a concentrations: A systematic review and meta-analysis of controlled trials
Stephen L. Atkin,Niki Katsiki,Maciej Banach,Dimitri P. Mikhailidis,Matteo Pirro,Amirhossein Sahebkar
Journal of Diabetes and its Complications. 2017;
[Pubmed]  [Google Scholar] [DOI]


Read this article